Company Performance: Strong financial results, increased profitability, and positive growth prospects typically drive stock prices higher. Conversely, poor performance can lead to price declines.

Industry Trends: The overall health and outlook of the pharmaceutical industry, including regulatory changes, technological advancements, and market competition, significantly impact stock valuation.

Market Sentiment: General investor confidence, risk appetite, and economic conditions influence buying and selling decisions, affecting stock prices regardless of company fundamentals.

Economic Factors: Interest rates, inflation, GDP growth, and exchange rates play a role in stock valuation by influencing corporate earnings and investment returns.

Regulatory Environment: Government policies, drug approval processes, and healthcare reforms can create opportunities or pose challenges, directly impacting pharmaceutical stock prices.

Competition: The intensity of competition from other pharmaceutical companies, including pricing pressures and market share battles, affects the company's revenue and profitability.

Product Pipeline: The success or failure of new drug development and approvals significantly impact investor confidence and future revenue projections.

Global Events: Geopolitical events, health crises, and global supply chain disruptions can cause volatility in stock prices, especially for companies with international operations.

Analyst Ratings: Investment analysts' recommendations and price targets can influence investor perception and trading activity, leading to price fluctuations.

Investor Sentiment: News articles, social media discussions, and overall investor sentiment surrounding the stock can lead to buying or selling pressure, impacting the price.